News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
542,103 Results
Type
Article (17067)
Company Profile (174)
Press Release (524766)
Multimedia
Podcasts (34)
Webinars (11)
Section
Business (182219)
Career Advice (542)
Deals (27458)
Drug Delivery (63)
Drug Development (60083)
Employer Resources (30)
FDA (11454)
Job Trends (9845)
News (263222)
Policy (21612)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (1120)
Accelerated approval (37)
ADA (22)
Adcomms (12)
Allergies (151)
Alliances (38192)
ALS (154)
Alzheimer's disease (1268)
Antibody-drug conjugate (ADC) (392)
Approvals (11910)
Artificial intelligence (561)
ASCO (202)
Autoimmune disease (289)
Automation (49)
Bankruptcy (271)
Best Places to Work (7887)
BIO (51)
Biologics (3)
BIOSECURE Act (19)
Biosimilars (227)
BioSpace Insights (58)
Biotechnology (119)
Bladder cancer (152)
Brain cancer (47)
Breast cancer (628)
Cancer (4520)
Cardiovascular disease (286)
Career advice (456)
Career pathing (13)
CAR-T (216)
CDC (13)
Celiac Disease (1)
Cell therapy (671)
Cervical cancer (37)
Clinical research (53821)
Collaboration (1739)
Commercialization (4)
Company closure (3)
Compensation (1509)
Complete response letters (66)
COVID-19 (1234)
CRISPR (87)
C-suite (967)
Cystic fibrosis (115)
Data (6803)
Denatured (12)
Depression (111)
Dermatology (85)
Diabetes (410)
Diagnostics (4730)
Digital health (46)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (316)
Drug pricing (48)
Drug shortages (2)
Duchenne muscular dystrophy (234)
Earnings (76909)
Editorial (27)
Employer branding (5)
Employer resources (29)
Events (94922)
Executive appointments (865)
FDA (14579)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (25)
Funding (1297)
Gene editing (185)
Generative AI (47)
Gene therapy (513)
GLP-1 (447)
Government (2096)
Grass and pollen (2)
Guidances (327)
Healthcare (10588)
Hematology (123)
HIV (64)
Huntington's disease (47)
IgA nephropathy (89)
Immunology and inflammation (194)
Immuno-oncology (88)
Indications (186)
Infectious disease (1486)
Inflammatory bowel disease (188)
Inflation Reduction Act (10)
Influenza (102)
Intellectual property (280)
Interviews (64)
IPO (13131)
IRA (17)
Job creations (2297)
Job search strategy (427)
JPM (13)
Kidney cancer (18)
Labor market (15)
Layoffs (146)
Leadership (5)
Legal (5512)
Licensing (9)
Liver cancer (54)
Longevity (30)
Lung cancer (616)
Lymphoma (306)
Machine learning (49)
Management (7)
Manufacturing (863)
Marketing (10)
MASH (148)
Medical device (9184)
Medtech (9339)
Mergers & acquisitions (15455)
Metabolic disorders (908)
mRNA (111)
Multiple sclerosis (155)
NASH (9)
Neurodegenerative disease (330)
Neuropsychiatric disorders (47)
Neuroscience (2428)
NextGen: Class of 2026 (3695)
Non-profit (1398)
Now hiring (29)
Obesity (313)
Opinion (109)
Ovarian cancer (185)
Pain (202)
Pancreatic cancer (234)
Parkinson's disease (284)
Partnered (24)
Patents (528)
Patient recruitment (604)
Peanut (58)
People (46424)
Pharmaceutical (36)
Pharmacy benefit managers (11)
Phase 1 (17355)
Phase 2 (23810)
Phase 3 (16757)
Pipeline (8671)
Policy (167)
Postmarket research (1739)
Preclinical (7574)
Press Release (68)
Prostate cancer (216)
Psychedelics (18)
Radiopharmaceuticals (221)
Rare diseases (839)
Real estate (3728)
Recruiting (11)
Regulatory (18208)
Reports (26)
Research institute (1173)
Resumes & cover letters (74)
Rett syndrome (44)
RNA editing (15)
RSV (60)
Schizophrenia (125)
Series A (237)
Series B (163)
Service/supplier (5)
Sickle cell disease (84)
Special edition (7)
Spinal muscular atrophy (110)
Sponsored (25)
Startups (2587)
State (1)
Stomach cancer (8)
Supply chain (71)
Tariffs (21)
The Weekly (22)
Vaccines (611)
Venture capital (47)
Weight loss (126)
Women's health (95)
Worklife (3)
Date
Today (13)
Last 7 days (265)
Last 30 days (1804)
Last 365 days (22877)
2026 (15021)
2025 (22595)
2024 (26484)
2023 (30295)
2022 (39076)
2021 (41717)
2020 (37691)
2019 (27178)
2018 (20437)
2017 (21900)
2016 (20929)
2015 (27365)
2014 (23905)
2013 (20081)
2012 (21990)
2011 (22354)
2010 (21596)
Location
Africa (344)
Alabama (83)
Alaska (3)
Arizona (332)
Arkansas (13)
Asia (23676)
Australia (2952)
California (13145)
Canada (3364)
China (909)
Colorado (518)
Connecticut (456)
Delaware (307)
Europe (39827)
Florida (1875)
Georgia (408)
Hawaii (4)
Idaho (53)
Illinois (803)
India (91)
Indiana (378)
Iowa (19)
Japan (458)
Kansas (107)
Kentucky (38)
Louisiana (35)
Maine (42)
Maryland (1478)
Massachusetts (9038)
Michigan (322)
Minnesota (626)
Mississippi (7)
Missouri (102)
Montana (21)
Nebraska (13)
Nevada (125)
New Hampshire (67)
New Jersey (2964)
New Mexico (17)
New York (3164)
North Carolina (1445)
North Dakota (11)
Northern California (6658)
Ohio (330)
Oklahoma (21)
Oregon (33)
Pennsylvania (2389)
Puerto Rico (25)
Rhode Island (39)
South America (542)
South Carolina (79)
South Dakota (1)
Southern California (5364)
Tennessee (133)
Texas (2067)
United States (43366)
Utah (407)
Vermont (1)
Virginia (186)
Washington D.C. (49)
Washington State (1030)
West Virginia (2)
Wisconsin (99)
Wyoming (1)
542,103 Results for "prellis biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prellis Biologics Enters Multi-Target Drug Discovery & Development Collaboration with Lilly to Advance Human Antibody Therapeutics
September 24, 2025
·
3 min read
Press Releases
Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts
European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.
August 12, 2026
·
2 min read
Press Releases
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
August 18, 2026
·
2 min read
Press Releases
USP Publishes Product-Specific Emerging Biologics Standards for Public Comment
Advancing efficiency and alignment in biologics development, through product-specific methods, to support broader availability of biologics, including biosimilars, for patients
June 1, 2026
·
4 min read
Insights
From sequence to scale: Gene editing’s new era in biologics manufacturing
In this episode of Denatured, you’ll hear from Jack Crawford, CEO of Demeetra, and Magnus Gustavsson, chief commercial officer at NorthX Biologics. We unpack the evolution of cell line development — CHO cells, targeted integration, transposases and the collaboration models speeding biologics from sequence to GMP.
July 10, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Regulatory
Lilly, FDA retatrutide biologic dispute comes to a head as submission nears
A legal dispute between the FDA and Eli Lilly over whether the highly anticipated obesity candidate retatrutide is indeed a biologic has come to a head as the company prepares to submit the medicine for approval.
August 5, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Cytovance Biologics Launches Standalone Analytical Services to Accelerate Biologics Development
August 18, 2026
·
3 min read
Insights
Biologics push CMOs/CDMOs to expand sterile fill-finish and prefilled syringe capacity
As biologics, biosimilars and GLP-1s drive demand for sterile drug products, CMOs and CDMOs are investing in fill-finish, lyophilization, inspection and packaging capacity to keep pace with a dynamic injectable market.
August 3, 2026
·
2 min read
·
Jennifer C. Smith-Parker
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
With PolyPeptide manufacturing peptides such as GLP-1 medicines, Samsung Biologics has identified the deal as a way to tap into fast-growing demand for obesity drug production services.
July 21, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
July 29, 2026
·
6 min read
1 of 54,211
Next
